IDH2 and glioblastoma: The obvious metabolic feature is that IDH wild type and IDH mutant astrocytoma have lower levels of broad-spectrum acylcarnitine than glioblastoma and oligodendroglioma, which indicates that glioblastoma and oligodendroglioma rely more on fatty acid oxidation as an energy source (23).